Overcoming a treatment barrier in treating hepatitis C in dialysis patients

2018 ◽  
Vol 31 (2) ◽  
pp. 193-193
Author(s):  
Kamolyut Lapumnuaypol ◽  
Eyob Feyssa
Keyword(s):  
Hepatitis C ◽  
Dialysis Patients ◽  
Treatment Barrier

Risk of death among chronic dialysis patients infected with hepatitis C virus

1998 ◽  
Vol 32 (4) ◽  
pp. 629-634 ◽  
Author(s):  
CO Stehman-Breen ◽  
S Emerson ◽  
D Gretch ◽  
RJ Johnson
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Risk Of Death

Treating hepatitis C virus in dialysis patients: How, when, and why?

2018 ◽  
Vol 32 (2) ◽  
pp. 152-158 ◽  
Author(s):  
Javier Pagan ◽  
Marco Ladino ◽  
David Roth
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Dialysis Patients

scholarly journals Indirect Evidence for Transfusion Role in Conditioning Hepatitis C Virus Prevalence among Dialysis Patients

Nephron ◽  
1991 ◽  
Vol 57 (3) ◽  
pp. 371-372 ◽  
Author(s):  
G.A. Moroni ◽  
P. Cori ◽  
F. Marelli ◽  
M. Del Prete ◽  
P. Padovese ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Indirect Evidence ◽  
Dialysis Patients ◽  
Virus Prevalence

Comparison of Three Different Tests for Assessment of Hepatitis C Virus in Dialysis Patients

1995 ◽  
Vol 15 (3) ◽  
pp. 241-245 ◽  
Author(s):  
Claudia Castelnovo ◽  
Giovanna Lunghi ◽  
Amedeo De Vecchi ◽  
Anna Grancini ◽  
Giovanna Como ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Sensitivity And Specificity ◽  
Cross Sectional Study ◽  
University Hospital ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Dialysis Unit ◽  
Recombinant Immunoblot Assay ◽  
Virus C

Objective To evaluate the relationship between hepatitis C virus antibodies (HCV-Ab) and viremia and to compare the prevalence of HCV-Ab and HCV viremia in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. Design Cross-sectional study. Setting Dialysis unit of a nephrology division in a public university hospital. Patients All dialysis patients who came for routine clinic visits during the study period. None denied informed consent. Forty-eight patients on HD and 79 on CAPD were examined. Intervention Blood samples were tested by second generation enzyme-Iinked immunosorbent assay (ELISA II) and recombinant immunoblot assay (RIBA II) to look for HCV-Ab and by the polymerase chain reaction (PCR) to look for HCV viremia. Results ELISA II was positive in 52% of HD patients and in 14% of CAPD patients. RIBA II was positive in 48% of HD patients and in 11% of CAPD patients. HCV viremia was positive by PCR in 41.6% of HD patients and in 12% of CAPD patients. Two of these PCR-positive patients did not show HCV-Ab by ELISA II and RIBA II. The sensitivity and specificity of ELISA II were 93% and 92%, the sensitivity and specificity of RIBA II were 86% and 94%. Conclusions Our data confirm a higher prevalence of HCV viremia in HD than in CAPD patients. The absence of Ab against virus C in 2 patients positive with PCR might be due to recent HCV infection or to weak virus replication or to a poor immune response.

Sign in / Sign up

Export Citation Format

Share Document